Peer-Reviewed Study Design Paper Published for PREDICTOM Alzheimer's Screening Initiative Featuring BrainCheck
BrainCheck Inc., a cognitive workflow platform, today highlighted the publication of a peer-reviewed study design paper for PREDICTOM — the large-scale European Alzheimer's early detection initiative in which BrainCheck Assess is serving as a cognitive assessment tool. The paper, published in The Journal of Prevention of Alzheimer's Disease, details the full protocol for a novel AI-driven screening platform designed to bring Alzheimer's diagnostics into the home and community care setting.
150 Practices Join BrainCheck in 2025 as New Cognitive Care Workflows Scale Nationwide
BrainCheck Inc., a digital cognitive assessment and care platform used by clinicians nationwide, today announced that more than 150 new practices and health systems adopted BrainCheck in 2025, expanding the platform to over 500 practices nationwide.
BrainCheck Awarded $1.5M Grant by US Small Business Innovation Research (SBIR) Program to Measure Effectiveness of Digital Cognitive Care Management Platform
BrainCheck Inc., developer of the innovative digital cognitive assessment and care management platform, today announced a $1.5M grant award from the Small Business Innovation Research (SBIR) program. Known as “America’s Seed Fund," SBIR is a U.S. government funding program for small businesses designed to advance commercialization of innovative solutions. The grant will be used to fund a new study to deploy BrainCheck® CARE™ in diverse patient populations and measure its ability to improve health outcomes and quality metrics for health systems and payors.
BrainCheck Launches Investigator Initiated Research (IIR) Grant Program For Brain and Cognitive Disorders Research
BrainCheck Inc., developer of an innovative digital cognitive assessment and care platform, today announced an Investigator Initiated Research (IIR) Grant Program to help fund research for evaluation, diagnosis, treatment and care for brain related disease. This includes, but is not limited to, Alzheimer's disease and related dementias (ADRD), post-operative delirium, stroke, traumatic brain injury, and post-acute Covid “brain fog”. Awardees will be provided one-year research funding and free access to the BrainCheck platform.
Peer-Reviewed Study Validates BrainCheck’s Digital Cognitive Test, Signaling Breakthrough for Future of Dementia Diagnosis
BrainCheck Inc., creator of the comprehensive cognitive assessment and care management platform for physicians, announced the publication of a peer-reviewed study in the Journal of Medical Internet Research (JMIR) Aging: A Computerized Cognitive Test Battery for Detection of Dementia and Mild Cognitive Impairment: Instrument Validation Study.
